“Peptide therapy” can mean different things depending on the clinic. Sometimes it refers to FDA-approved prescription peptide medications (for example, certain metabolic or hormone-signaling medications).

Other times it refers to compounded peptides prepared by a pharmacy for an individual patient, or even “research peptides” marketed online (which should not be used as medical treatment).

Because of that mix, the safest rule is simple: if a peptide is being used as a prescription medication, it should only be provided through a licensed clinician with legal prescribing authority, with appropriate screening and follow-up.

Key Points

In the U.S., prescription peptide medications (including compounded peptides) require a prescription written by a licensed clinician who has prescribing authority under state law–most commonly physicians, and in many settings nurse practitioners and physician assistants (depending on state rules and supervision requirements).

Compounded products are not FDA-approved, so it matters even more that a clinic is conservative about candidacy, dosing, sourcing, and monitoring.

What “Peptide Therapy” Usually Includes

A common point of confusion is that peptides aren’t one category of treatment–they’re a type of molecule used in many legitimate medications, and they’re also used in some experimental or poorly regulated products. A responsible clinic should be able to tell you which of these buckets you’re actually discussing:

Prescription peptide medications (FDA-approved): These are regulated drugs with established indications and known safety profiles within medical guidelines.

Compounded peptides (patient-specific): These may be prescribed when a clinician determines a specific patient need that can’t be met by an FDA-approved product, and they must be produced under compounding rules. They still require medical oversight, and patients should understand that compounding is different from FDA approval.

“Research peptides” sold online: If a product is labeled “research use only” or “not for human consumption,” that’s a major red flag for clinical use.

Who Can Prescribe Peptides In A Regenerative/Midlife Clinic Setting?

For a templated site that serves many practices, the cleanest and most accurate language is:

A peptide medication can be prescribed by a licensed medical clinician who has prescribing authority in that jurisdiction and is practicing within their scope (often an MD/DO, and in many states an NP or PA under applicable state rules).

The right prescriber is the one who can also do the full job–screen candidacy, check contraindications, review medications, order and interpret labs when needed, and provide ongoing monitoring.

Because many midlife symptoms overlap (fatigue, body composition changes, sleep disruption, pain, low libido, “brain fog”), peptide discussions should never happen in a vacuum.

The best prescribers connect peptide decisions to a broader plan that includes strength training, protein intake, sleep improvement, and metabolic support–not just a vial and a dosing schedule.

Learn more about Peptides and Regenerative Medicine

How To Vet A Clinic Before Starting Peptides

A good clinic can answer these questions clearly, without defensiveness:

They can tell you exactly what peptide you’re being offered, what it’s intended to do, and what outcomes you’ll track. They can explain whether it’s FDA-approved or compounded, and why that route makes sense for your case.

They review your health history and medications first. That matters because peptide medications can interact with other meds, affect appetite, blood sugar, GI function, blood pressure, or hormonal systems depending on the therapy.

They have a monitoring plan. You should know what follow-ups look like, what side effects to watch for, and what would prompt stopping or changing course.

Safety

Be cautious if a clinic says peptides are “natural so they’re automatically safe,” guarantees outcomes, or pushes large bundles before you’ve even had a medical evaluation. Also be cautious if a clinic won’t tell you whether something is FDA-approved or compounded, or if they suggest products labeled “research use only” for human treatment. Those patterns usually predict poor oversight and higher risk.

Sources & Citations

The evidence for “peptide therapy” is best represented by the research behind therapeutic peptides as a drug class–how they’re developed, where they’re used clinically, and what challenges (stability, delivery, safety) matter in real-world practice.

• Therapeutic Peptides: Current Applications And Future Directions (PMC)
• Recent Advances In The Development Of Therapeutic Peptides (PMC)
• Therapeutic Peptides: Recent Advances In Discovery And Clinical Applications (PMC)
• Emerging Peptide Nanomedicine To Regenerate Tissues And Organize Cells (PMC)

Next Steps

If you’re considering peptide therapy, the safest next step is a structured consult to confirm what category of peptide you’re considering (FDA-approved vs compounded), whether you’re a candidate, and how your plan will be monitored over time.

Ready to talk it through? Book a discovery consult with our team.